Ansana, a Dutch health tech company rooted in Maastricht, is extending its innovation in healthcare sterilisation technology with a successful funding round of €1.5 million. The funds aim to broaden the capabilities of SteriWatch, their advanced sterilisation system designed to improve hospital operations and patient safety. Ansana’s ambitions are met with financial backing from investors including NLC Health Ventures, Healthliant Ventures, and other private entities, highlighting the industry’s focus on sustainable healthcare solutions.
Ansana has consistently advanced its sterilisation solutions, marking progress in healthcare sustainability. Their technology, known as SteriWatch, combines intelligent sterilisation containers with cutting-edge sensor systems offering real-time tracking. Past initiatives showed Ansana’s commitment to improving operational efficiencies but did not yet integrate the fully digital workflow proposed now. The current innovations aim for broader impact and efficiency in hospital and pharmaceutical workflows, setting a new benchmark for smart sterilisation practices.
How Does SteriWatch Work?
SteriWatch stands out by integrating sensors and data modules within sterilisation containers, catering directly to healthcare’s intricate needs. The technology maintains sterility and ensures full traceability during the lifecycle of surgical instruments, reducing patient risk and enhancing operational efficiencies. The implementation of real-time track-and-trace capabilities specifies advancements from traceability to ecological impact by removing consumable dependence, aiming for a reduced carbon footprint.
What Are the Strategic Goals?
With the recent investment, Ansana aspires to develop a minimum viable product and achieve ISO 13485 certification, setting the groundwork for technology scaling. Their plan includes pilot projects within clinical settings, creating a pathway for broader commercial rollout and ongoing process improvement. These steps align with the strategic growth objectives of healthcare systems and hospital groups that anticipate long-term improvements and sustainability.
Healthliant Ventures’ partnership illustrates tangible opportunities at Tanner Health System, benefiting from their real-world settings to test and expand SteriWatch’s capabilities. Steve West, MD at Healthliant Ventures, expresses confidence in the collaboration:
“Partnering with Ansana underscores our commitment to supply the sterilisation departments from Tanner Health System with smart technology that enhances patient safety and operational efficiency.”
This alliance provides a conducive environment for the pilot of advanced sterilisation systems, promising integration within surgical instrument reprocessing workflows.
Dominique Surinx, CEO of Ansana, underscores the broader impact of SteriWatch:
“Next to the immediate patient and operational benefits, SteriWatch supports the strategic growth objectives of healthcare systems and hospital groups.”
This focus highlights a centralised approach to managing surgical instrument reprocessing, reflecting Ansana’s pursuit in establishing a foundation for sustainable process improvements globally.
Ansana is poised to redefine aspects of healthcare technology through innovation and strategic partnerships. As healthcare facilities continually seek methods to manage operational costs, improve patient outcomes, and reduce environmental impact, solutions like SteriWatch are increasingly vital. The company’s recent funding round is expected to propel these developments, driving improved safety and efficiency in hospital workflows globally.
